Author:
Elshama Said Said,Abdallah Metwally E.,Abdel-Karim Rehab I.
Abstract
Despite the widespread application of zinc oxide nanoparticles in biomedicine, their use is still a controversial issue. Zinc oxide nanoparticles were reported to have therapeutic benefits. However, they were reported to have toxicological hazards as well. Several studies reported the antibacterial, anticancer, antioxidant, and immunomodulatory effects of zinc oxide nanoparticles. Additionally, zinc oxide nanoparticles were used in sunscreens. Furthermore, the ability to use zinc oxide nanoparticles as an adjuvant treatment to alleviate the toxic effects of chemotherapeutic drugs has been reported. However, zinc oxide nanoparticles were shown to induce toxic effects in different body organs and systems. The affected organs included liver, spleen, kidney, stomach, pancreas, heart and lung. In addition, zinc oxide nanoparticles were reported to adversely affect the neurological system, lymphatic system, hematological indices, sex hormones levels, and fetal development. The toxic effects of zinc oxide nanoparticles were based on their concentration, their dose, the route of their administration, and the time of exposure to those particles. Thus, it is crucial to assess their efficacy and safety to determine their toxicological risks and therapeutic benefits.
Publisher
Bentham Science Publishers Ltd.
Reference48 articles.
1. Handy RD, von der Kammer F, Lead JR, Hassellöv M, Owen R, Crane M.
The ecotoxicology and chemistry of manufactured nanoparticles.
Ecotoxicology
2008;
17
(4)
: 287-314.
2. Kao YY, Chen YC, Cheng TJ, Chiung YM, Liu PS.
Zinc oxide nanoparticles interfere with zinc ion homeostasis to cause cytotoxicity.
Toxicol Sci
2012;
125
(2)
: 462-72.
3. Espanani HR, Fazilati M, Sadeghi L, Yousefi BV, Bakhshiani S, Amraie E.
Investigation the zinc oxide nanoparticle’s effect on sex hormones and cholesterol in rat.
Int Res J Biol Sci
2013;
2
(8)
: 54-8.
4. McNeil SE.
Nanoparticle therapeutics: a personal perspective.
Wiley Interdiscip Rev Nanomed Nanobiotechnol
2009;
1
(3)
: 264-71.
5. Vizirianakis IS.
Nanomedicine and personalized medicine toward the application of pharmacotyping in clinical practice to improve drug-delivery outcomes.
Nanomedicine (Lond)
2011;
7
(1)
: 11-7.
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献